M&A TRANSACTION · 2023
Evoqua Hemodialysis Concentrates Business acquired by Rockwell Medical, Inc.
$16.0M· 4.9x EBITDA· 0.90x revenue
Target
Evoqua Hemodialysis Concentrates Business
Acquirer
Rockwell Medical, Inc.
Strategic buyer
Disclosed financials at time of acquisition
Revenue
$18.0M
EBITDA
$3.3M
Deal Value
$16.0M
EV/EBITDA
4.9x
Context
This $16.0M acquisition of Evoqua Hemodialysis Concentrates Business by Rockwell Medical, Inc. sits in the medical devices sub-vertical. The 4.9x EBITDA multiple paid in 2023 can be compared against the population median for medical devices transactions of similar size on our Medical Devices valuation hub. Rockwell Medical, Inc. is acquiring as a strategic buyer; see how strategic acquirers typically price medical devices businesses on our Medical Devices strategic buyer-pool page.
Source
Data sourced from Press release. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own medical devices
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
Compare your business to the Evoqua Hemodialysis Concentrates Business acquisition.